000			04020cam a22004937a 4500
001			18390855
003			OSt
005			20240305192054.0
008			141201s2015 enka b 001 0 eng
010			_a 2014958214
016	7		_a101664500 _2DNLM
020			_a9780199689774 _q(pbk.)
020			_a0199689776 _q(pbk.)
035			_a(OCoLC)ocn907177917
040			_aNLM _beng _cNLM _dBTCTA _dBDX _dESU _dYDXCP _dCHVBK _dOCLCF _dN15 _dOCLCO _dLND _dCDX _dUAB _dDLC
042			_anlmcopyc _alccopycat
050	0	0	_aRM267 _b.A55 2015
060	0	0	_a2015 G-765
060	1	0	_aQV 250
082	0	4	_a616.90461
245	0	0	_aAntimicrobial chemotherapy / _cPeter Davey ... [et al.].
250			_a7th ed.
260			_aOxford, U.K. ; _aNew York : _bOxford University Press, _c2015.
300			_ax, 419 p. : _bill. ; _c25 cm.
500			_aPreceded by: Antimicrobial chemotherapy / Roger Finch ... [et al.]. 6th ed. 2012.
504			_aIncludes bibliographical references and index.
505	0		_aPart 1. General properties of antimicrobial agents. 1. Mechanisms of action and resistance to modern antibacterial with a history of their development ; 2. Inhibitors of bacterial cell wall synthesis ; 3. Inhibitors of bacterial protein synthesis ; 4. Synthetic antibacterial agents and miscellaneous antibiotics ; 5. Antiviral agents ; 6. Antiretroviral agents ; 7. Drugs used in the treatment of viral hepatitis ; 8. Antifungal agents ; 9. Antiprotozoal and anthelminthic agents -- Part 2. Resistance to antimicrobial agents. 10. The problem of resistance ; 11. The genetics and mechanisms of acquired resistance -- Part 3. General principles of usage of antimicrobial agents. 12. Laboratory investigations and the treatment of infection ; 13. General principles of the treatment of infection ; 14. Pharmacokinetic and pharmacodynamics principles ; 15. Prescribing in special groups : effects of age, pregnancy, body weight, hepatic and renal impairment 16: Outpatient parenteral antimicrobial therapy ; 17. Adverse drug reactions and patient safety ; 18. Chemoprophylaxis and immunisation ; 19. Guidelines, formularies, and antimicrobial policies ; 20. Antimicrobial stewardship, surveillance of antimicrobial consumption and its consequences -- Part 4. Therapeutic use of antimicrobial agents. 21. Respiratory tract infections ; 22. Topical use of antimicrobial agents ; 23. Urinary tract infections ; 24. Sexually transmitted infections ; 25. Gastrointestinal infections ; 26. Serious bacterial bloodstream infections ; 27. Bone and joint infections ; 28. Infections of the central nervous system ; 29. Skin and soft tissue infections ; 30. Tuberculosis and other mycobacterial diseases ; 31. Infections in immunocompromised patients including HIV/AIDs ; 32. Viral infections ; 33. Management of HIV infection ; 34. Treatment of chronic viral hepatitis ; 35. Parasitic disease ; 36. The development and marketing of antimicrobial drugs
650		0	_aAnti-infective agents. _916163
650		0	_aCommunicable diseases _xChemotherapy. _916164
650	1	2	_aAnti-Infective Agents _xtherapeutic use. _93505
650	2	2	_aAnti-Infective Agents _xpharmacology. _916165
650	2	2	_aDrug Resistance, Microbial. _912500
650	2	2	_aInfection _xdrug therapy. _93507
650		7	_aAnti-infective agents. _2fast _0(OCoLC)fst00810345 _916163
650		7	_aCommunicable diseases _xChemotherapy. _2fast _0(OCoLC)fst00869885 _916164
700	1		_aDavey, Peter G. _916166
856	4	2	_3Contributor biographical information _uhttp://www.loc.gov/catdir/enhancements/fy1604/2014958214-b.html
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy1604/2014958214-d.html
856	4	1	_3Table of contents only _uhttp://www.loc.gov/catdir/enhancements/fy1604/2014958214-t.html
906			_a7 _bcbc _ccopycat _d2 _eepcn _f20 _gy-gencatlg
942			_2ddc _cEB
999			_c908 _d908